Patent Reform Bill Gets Cool Reception From Rx Industry; Damage Cap Is Worry
A new patent reform bill introduced in Congress is likely to undergo revisions in the face of criticism from the pharmaceutical industry
A new patent reform bill introduced in Congress is likely to undergo revisions in the face of criticism from the pharmaceutical industry